Document Detail


Does the immobilizing effect of thiopental in brain exceed that of halothane?
MedLine Citation:
PMID:  11964608     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Recent studies suggest that anesthetics such as isoflurane act in the spinal cord to suppress movement that occurs during noxious stimulation. The authors examined the effect of halothane and thiopental on suppression of noxious-evoked movement using a model of differential anesthetic delivery. They hypothesized that halothane and thiopental, similar to isoflurane, would suppress movement primarily via an action in spinal cord. METHODS: Goats were anesthetized and prepared for differential anesthetic delivery. Anesthesia was maintained with halothane (n = 5) or thiopental (n = 5). Anesthetic requirements were determined (noxious clamp on a dewclaw for 1 min) during halothane or thiopental (via infusion) delivery to the whole body and delivery only to the head. RESULTS: Control (whole body) halothane requirement was 0.9 +/- 0.2%; halothane requirement in the head during differential delivery was 3.4 +/- 1% (P < 0.01). During selective halothane delivery, the electroencephalogram was greatly depressed or was isoelectric even though the animals moved during noxious stimulation. Control (whole body) plasma thiopental requirement was 20 +/- 10 microg/ml. When thiopental was selectively delivered to the head, the electroencephalogram was active in all five animals, and cranial thiopental requirement was 42 +/- 6 microg/ml (P < 0.01). CONCLUSION: These data suggest that halothane and thiopental, like isoflurane, act in spinal cord to suppress movement occurring with noxious stimulation. However, halothane appears to be less potent in the brain as evidenced by the electroencephalogram data, suggesting that action in spinal cord plays a more significant role for halothane than for thiopental.
Authors:
Joseph F Antognini; Earl Carstens; Richard Atherley
Related Documents :
2607268 - An evaluation of volumes and concentrations of lidocaine in human inferior alveolar ner...
697078 - Ventilatory responses to hypoxia and hypercapnia during halothane sedation and anesthes...
2007098 - Anatomic spread of india ink in the human intercostal space with radiographic correlation.
2316878 - Different effects of halothane and enflurane on diaphragmatic contractility in vivo.
6219458 - Progressive resistance exercise training of the hypotrophic quadriceps muscle in man. t...
3087938 - A new method for detecting anaerobic threshold by gas exchange.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Anesthesiology     Volume:  96     ISSN:  0003-3022     ISO Abbreviation:  Anesthesiology     Publication Date:  2002 Apr 
Date Detail:
Created Date:  2002-04-19     Completed Date:  2002-05-02     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  1300217     Medline TA:  Anesthesiology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  980-6     Citation Subset:  AIM; IM    
Affiliation:
Department of Anesthesiology and Pain Medicine, University of California-Davis, Davis, California 95616, USA. jfantognini@ucdavis.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anesthetics, Inhalation / pharmacology*
Anesthetics, Intravenous / pharmacology*
Animals
Brain / drug effects*
Electroencephalography / drug effects
Female
Goats
Halothane / pharmacology*
Isoflurane / pharmacology
Spinal Cord / drug effects*
Thiopental / pharmacology*
Grant Support
ID/Acronym/Agency:
GM 61283/GM/NIGMS NIH HHS; GM57970/GM/NIGMS NIH HHS
Chemical
Reg. No./Substance:
0/Anesthetics, Inhalation; 0/Anesthetics, Intravenous; 151-67-7/Halothane; 26675-46-7/Isoflurane; 76-75-5/Thiopental

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Accelerated arteriolar gas embolism reabsorption by an exogenous surfactant.
Next Document:  Droperidol inhibits GABA(A) and neuronal nicotinic receptor activation.